ALBANY MOLECULAR RESEARCH INC 4
4 · ALBANY MOLECULAR RESEARCH INC · Filed Dec 1, 2016
Insider Transaction Report
Form 4
Hagen Steven R
VP Pharmaceutical Dev & Mfg
Transactions
- Sale
Common Stock
2016-11-30$16.71/sh−9,000$150,390→ 34,913 total - Exercise/Conversion
Common Stock
2016-11-30$13.20/sh+9,000$118,800→ 43,913 total - Exercise/Conversion
Option to Purchase Common Stock
2016-11-30$13.20/sh−9,000$118,800→ 0 totalExercise: $13.20Exp: 2018-11-03→ Common Stock (9,000 underlying)
Footnotes (1)
- [F1]Option grant was fully exercisable on November 3, 2012